135 related articles for article (PubMed ID: 27601079)
21. [Periocular basal cell carcinoma treatment tendencies].
García Martín E; Fernández Tirado FJ
Arch Soc Esp Oftalmol; 2010 Aug; 85(8):261-2. PubMed ID: 21130940
[No Abstract] [Full Text] [Related]
22. Successful treatment of multiple superficial basal cell carcinomas with topical imiquimod: case report and review of the literature.
Drehs MM; Cook-Bolden F; Tanzi EL; Weinberg JM
Dermatol Surg; 2002 May; 28(5):427-9. PubMed ID: 12030878
[TBL] [Abstract][Full Text] [Related]
23. Vitiligo-like depigmentation induced by imiquimod treatment of superficial basal cell carcinoma.
Sriprakash K; Godbolt A
Australas J Dermatol; 2009 Aug; 50(3):211-3. PubMed ID: 19659986
[TBL] [Abstract][Full Text] [Related]
24. [Photodynamic therapy vs imiquimod].
Serra-Guillén C; Nagore E; Guillén C
Actas Dermosifiliogr; 2012; 103(6):488-501. PubMed ID: 22178262
[TBL] [Abstract][Full Text] [Related]
25. Long-term efficacy and safety of imiquimod 5% and fluorouracil 1% creams in medical monotherapy of complex eyelid basal cell carcinomas.
Singh M; Mehta Grewal A; Singh H; Sharma M; Kaur M; Gupta P; Zadeng Z
Eur J Ophthalmol; 2022 Jul; 32(4):2093-2100. PubMed ID: 34320864
[TBL] [Abstract][Full Text] [Related]
26. Case study: Imiquimod 5% cream in the treatment of a large nodular basal cell carcinoma.
Shulstad RM
Dermatol Nurs; 2009; 21(2):86-7. PubMed ID: 19507375
[TBL] [Abstract][Full Text] [Related]
27. Role of non-surgical therapies in the management of periocular basal cell carcinoma and squamous intra-epidermal carcinoma: a case series and review of the literature.
Attili SK; Ibbotson SH; Fleming C
Photodermatol Photoimmunol Photomed; 2012 Apr; 28(2):68-79. PubMed ID: 22409709
[TBL] [Abstract][Full Text] [Related]
28. Imiquimod cream efficacy in the treatment of periocular nodular basal cell carcinoma: a non-randomized trial.
de Macedo EM; Carneiro RC; de Lima PP; Silva BG; Matayoshi S
BMC Ophthalmol; 2015 Apr; 15():35. PubMed ID: 25885553
[TBL] [Abstract][Full Text] [Related]
29. Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion.
Sterry W; Ruzicka T; Herrera E; Takwale A; Bichel J; Andres K; Ding L; Thissen MR
Br J Dermatol; 2002 Dec; 147(6):1227-36. PubMed ID: 12452875
[TBL] [Abstract][Full Text] [Related]
30. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe.
Schulze HJ; Cribier B; Requena L; Reifenberger J; Ferrándiz C; Garcia Diez A; Tebbs V; McRae S
Br J Dermatol; 2005 May; 152(5):939-47. PubMed ID: 15888150
[TBL] [Abstract][Full Text] [Related]
31. Nonsyndromic multiple basal cell carcinomas successfully treated with imiquimod 5% cream.
Kocabaş E; Ermertcan AT; Bilaç C; Bilaç DB; Temiz P
Cutan Ocul Toxicol; 2010 Dec; 29(4):300-2. PubMed ID: 20684662
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo.
Urosevic M; Maier T; Benninghoff B; Slade H; Burg G; Dummer R
Arch Dermatol; 2003 Oct; 139(10):1325-32. PubMed ID: 14568837
[TBL] [Abstract][Full Text] [Related]
33. Superficial basal cell carcinoma treated with imiquimod 5% topical cream for a 4-week period: a case series.
Ruiz-Villaverde R; Sánchez-Cano D; Burkhardt-Pérez P
J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):828-31. PubMed ID: 19646136
[TBL] [Abstract][Full Text] [Related]
34. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial.
Bath-Hextall F; Ozolins M; Armstrong SJ; Colver GB; Perkins W; Miller PS; Williams HC;
Lancet Oncol; 2014 Jan; 15(1):96-105. PubMed ID: 24332516
[TBL] [Abstract][Full Text] [Related]
35. Imiquimod: in superficial basal cell carcinoma.
Oldfield V; Keating GM; Perry CM
Am J Clin Dermatol; 2005; 6(3):195-200; discussion 201-2. PubMed ID: 15943496
[TBL] [Abstract][Full Text] [Related]
36. Periocular Melanoma In Situ Treated With Imiquimod.
Elia MD; Lally SE; Hanlon AM; Choi JN; Servat JJ; Shields JA; Shields CL; Levin F
Ophthalmic Plast Reconstr Surg; 2016; 32(5):371-3. PubMed ID: 26325381
[TBL] [Abstract][Full Text] [Related]
37. Multiple and clustered eruptive epidermoid cysts following treatment with topical imiquimod.
Nasca MR; De Pasquale R; Micali G
Dermatology; 2007; 215(4):352-3. PubMed ID: 17911995
[TBL] [Abstract][Full Text] [Related]
38. Reversed actinic damage in two children with xeroderma pigmentosum treated with topical imiquimod.
Latour I; Hernández-Martín A; Ged C; Knöpfel N; Taïeb A; Torrelo A
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):e282-e284. PubMed ID: 29377344
[No Abstract] [Full Text] [Related]
39. Treatment of various types of basal cell carcinoma with topical 5% imiquimod in the elderly who refused surgical intervention: a case series.
Kaçar SD; Özuğuz P; Erkan F; Karaca Ş
J Dermatolog Treat; 2015 Apr; 26(2):165-7. PubMed ID: 24731081
[TBL] [Abstract][Full Text] [Related]
40. Imiquimod 5% cream use for the treatment of basal cell carcinomas in elderly patients, in long-term care facilities, not amenable to surgical or radiation therapy.
Ohson K; DesGroseilliers JP; Weatherhead S; Weatherhead L
J Cutan Med Surg; 2006; 10(4):201-3. PubMed ID: 17234120
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]